Stay updated on Pembrolizumab for Cancer of Unknown Primary Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added; notices about government funding and Revision: v3.4.1 have been removed.
    Difference
    0.5%
    Check dated 2026-02-11T10:01:19.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page adds a government funding notice, a 'Results Submitted' indicator, and updates the revision to v3.4.1, replacing the previous 'No Results Posted' status and v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-04T06:52:42.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Explicit site locations now show three UK sites: The Royal Marsden Hospitals at Sutton and London, Sutton (Surrey), and Guy's Cancer Centre in London. The study status has been updated to Completed.
    Difference
    2%
    Check dated 2026-01-28T04:48:41.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no visible changes to study details or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:57:10.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    A 'Last known status' entry was added, listing Imperial College London with the date 2023-12 and a verification status of Unknown.
    Difference
    0.4%
    Check dated 2026-01-06T22:18:55.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-30T16:20:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Cancer of Unknown Primary Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page.